NEW YORK (GenomeWeb News) - Codon Devices plans to open a new UK headquarters to service customers in European markets, the company said today.
The Cambridge, Mass.-based synthetic biology firm described the move as a "major step" toward its global expansion goals.
Codon Devices said it has appointed Michael Dyson, formerly managing director of Sequenom, to run the UK office and manage the European sales force.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.